Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Beat the Clock: Delayed Furosemide Increases Early Mortality in Acute Heart Failure
Session:
Sessão de Posters 11 - Dos digitálicos aos diuréticos no espectro da insuficiência cardíaca
Speaker:
João Mendes Cravo
Congress:
CPC 2026
Topic:
D. Heart Failure
Theme:
11. Acute Heart Failure
Subtheme:
11.4 Acute Heart Failure– Treatment
Session Type:
Posters Eletrónicos
FP Number:
---
Authors:
João Cravo; Marta Vilela; João Temtem; Ana Francês; Fátima Salazar; Nuno Lousada; Joana Rigueira; Rafael Santos; Doroteia Silva; Fausto Pinto; Dulce Brito; João Agostinho
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><strong>Introduction:</strong></span></span></span><br /> <span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000">Timely therapy is central in acute heart failure, but the real-world impact of delays in intravenous (IV) diuretics remains unclear. This study examined whether time from emergency department (ED) arrival to first IV furosemide was associated with admission, in-hospital mortality, and 1-year outcomes.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><strong>Methods:</strong></span></span></span><br /> <span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000">We performed a retrospective single-center study of patients that went to the ED in 2023 with acute heart failure and received IV furosemide. Demographic, clinical, laboratory, and treatment variables were extracted from electronic records. Outcomes included admission, length of stay, in-hospital mortality, and 1-year mortality. Group comparisons used Mann–Whitney U or χ² tests; logistic regression assessed associations between delay and outcomes. ROC analysis identified an optimal delay threshold, applied in Kaplan–Meier and Cox models.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><strong>Results:</strong></span></span></span><br /> <span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000">Among 305 patients (mean age 81 ± 11 years; 63% female), comorbidities were common: hypertension in 82%, atrial fibrillation in 45%, ischemic heart disease in 22% and diabetes in 38%. Median NT-proBNP was 12,683 pg/mL; mean estimated glomerular filtration rate, 47 ± 22 mL/min; mean LVEF, 51±13%. First furosemide dose averaged 46 ± 20 mg, with a mean administration delay of 10 ± 14 hours. Overall, 166 patients (55%) were admitted (median stay 9 days); 30 (10%) died in-hospital and 71 (23%) died within one year.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000">Admitted patients had longer delays than discharged patients (6.8 vs 5.0 h; p = 0.021), and each additional hour increased odds of admission by 2.3% (OR 1.023; p = 0.029). In-hospital deaths had substantially longer delays (9.7 vs 5.3 h; p = 0.029); each hour increased odds of death by 3.4% (OR 1.034; p < 0.001). ROC analysis identified 10 hours as the optimal cut-off for predicting early mortality. Patients treated after ≥10 hours had higher early mortality (HR 2.38; 95% CI 1.16–4.87; p = 0.017), with early and persistent Kaplan–Meier separation. Delay was initially linked to 1-year mortality (OR 1.022; p = 0.012), but this association disappeared after excluding in-hospital deaths, indicating the long-term effect was driven by early mortality.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><strong>Conclusion:</strong></span></span></span><br /> <span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000">Delayed IV furosemide, especially beyond 10 hours, was associated with increased admission and markedly higher in-hospital and short-term mortality. The effect did not persist after discharge, suggesting the harm of delayed treatment occurs early. Timely furosemide administration in the ED is critical to improve outcomes.</span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site